Aids drug gives hope to Africa
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.AN AFFORDABLE answer to the Aids epidemic ravaging Africa was tantalisingly floated at the 11th African Conference on Aids last week in Lusaka.
Nevirapine, one of a new generation of anti-Aids drugs, has been found to reduce significantly the risk of transmission of HIV from mother to child, according to Ugandan medical researchers. Crucially, at $4 (pounds 2.50) a course, Nevirapine costs a fraction of AZT (pounds 95 a course), which has successfully cut down mother to child transmission in the West, but has remained out of the financial reach of poverty-stricken Africa. While the HIV virus is considered under control in the West, it is devastating the African continent, where Aids has already claimed 11.5 million lives, and infected 34 million people .
"Nevirapine gives us hope," said Chewe Luo, a Zambian paediatrician, who told the conference there was now a need for large-scale testing of the drug. "The high costs of Aids drugs has always been the major obstacle to reducing mother-to-child transmission rates." She said the Ugandan study showed that 50 per cent of the women who received Nevirapine did not pass on the virus to their babies.
The hopes invested in Nevirapine show the sheer desperation in Africa to find an affordable solution to the epidemic, which has brought a long line of "miracle" medical answers and quack cures. Some African traditional healers have made a fortune preying on Aids patients.
In South Africa, where President Thabo Mbeki's government is attempting to import cheap substitutes for AZT and other anti-Aids drugs, in the face of vehement opposition from multinational pharmaceutical companies, Virodene has been the most notorious "miracle" to emerge. Though based on a toxic industrial solvent, and rejected by the medical establishment, Virodene was championed by Mr Mbeki before he became president, amid allegations that support for the drug was influenced by the offer of shares in Virodene to the ANC.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments